News
A new study finds lower rates of pancreaticobiliary complications in patients with sludge- or microlithiasis-induced acute ...
Gallbladder cancer, a rare malignancy affecting the organ storing bile, often presents without early symptoms, leading to ...
Weight loss drugs like Ozempic have gained a lot of popularity However these medications are not without side effects One ...
1d
MedPage Today on MSNNSAIDs and Microscopic Colitis; Fundoplication for GERD; Novel Drug Succeeds in MASHThe American Gastroenterological Association applauded the Supreme Court's Kennedy v. Braidwood decision, which preserves ...
A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the ...
The US Food and Drug Administration (FDA) has issued an urgent warning about tianeptine – a substance marketed as a dietary ...
University at Buffalo researcher Viviana Monje and colleagues awarded $1.2 million grant to study how popular aquarium fish ...
Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...
Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma.
Gallstone disease is linked to metabolic disorders, such as obesity, diabetes, and metabolic dysfunction-associated steatotic liver disease.
Randy Moss had a scary health scare that kept him sidelined from his ESPN gig. Today, we have an update on his future status.
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results